IL147071A0 - Nucleic and proteinic acids corresponding to human gene abc1 - Google Patents
Nucleic and proteinic acids corresponding to human gene abc1Info
- Publication number
- IL147071A0 IL147071A0 IL14707100A IL14707100A IL147071A0 IL 147071 A0 IL147071 A0 IL 147071A0 IL 14707100 A IL14707100 A IL 14707100A IL 14707100 A IL14707100 A IL 14707100A IL 147071 A0 IL147071 A0 IL 147071A0
- Authority
- IL
- Israel
- Prior art keywords
- proteinic
- nucleic
- human gene
- acids corresponding
- abc1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Child & Adolescent Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9907684A FR2795091B1 (fr) | 1999-06-17 | 1999-06-17 | Acides nucleiques et proteines du gene abc1 humain et leur application en therapie et diagnostic |
US14712899P | 1999-08-04 | 1999-08-04 | |
PCT/FR2000/001595 WO2000078970A1 (fr) | 1999-06-17 | 2000-06-08 | Acides nucleiques et proteines correspondant au gene abc1 humain |
Publications (1)
Publication Number | Publication Date |
---|---|
IL147071A0 true IL147071A0 (en) | 2002-08-14 |
Family
ID=26234994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14707100A IL147071A0 (en) | 1999-06-17 | 2000-06-08 | Nucleic and proteinic acids corresponding to human gene abc1 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1190063A1 (xx) |
JP (1) | JP2003503026A (xx) |
KR (1) | KR20020012279A (xx) |
AU (1) | AU5540800A (xx) |
BR (1) | BR0011724A (xx) |
CA (1) | CA2375771A1 (xx) |
HU (1) | HUP0204524A2 (xx) |
IL (1) | IL147071A0 (xx) |
MX (1) | MXPA01013062A (xx) |
NO (1) | NO20016089L (xx) |
WO (1) | WO2000078970A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1100895B1 (en) | 1999-03-15 | 2007-06-13 | University of British Columbia | Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
FR2815970A1 (fr) * | 2000-10-31 | 2002-05-03 | Aventis Pharma Sa | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection |
WO2002036770A2 (fr) * | 2000-10-31 | 2002-05-10 | Aventis Pharma S.A. | Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection |
KR100623128B1 (ko) * | 2002-01-02 | 2006-09-14 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
CN112442114A (zh) * | 2019-08-29 | 2021-03-05 | 渥太华Hdl药物研发公司 | 一种多肽及其应用 |
-
2000
- 2000-06-08 KR KR1020017016224A patent/KR20020012279A/ko not_active Application Discontinuation
- 2000-06-08 JP JP2001505712A patent/JP2003503026A/ja not_active Withdrawn
- 2000-06-08 WO PCT/FR2000/001595 patent/WO2000078970A1/fr not_active Application Discontinuation
- 2000-06-08 IL IL14707100A patent/IL147071A0/xx unknown
- 2000-06-08 BR BR0011724-2A patent/BR0011724A/pt not_active IP Right Cessation
- 2000-06-08 CA CA002375771A patent/CA2375771A1/fr not_active Abandoned
- 2000-06-08 AU AU55408/00A patent/AU5540800A/en not_active Abandoned
- 2000-06-08 HU HU0204524A patent/HUP0204524A2/hu unknown
- 2000-06-08 EP EP00940477A patent/EP1190063A1/fr not_active Withdrawn
- 2000-06-08 MX MXPA01013062A patent/MXPA01013062A/es unknown
-
2001
- 2001-12-13 NO NO20016089A patent/NO20016089L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1190063A1 (fr) | 2002-03-27 |
KR20020012279A (ko) | 2002-02-15 |
MXPA01013062A (es) | 2002-06-04 |
JP2003503026A (ja) | 2003-01-28 |
BR0011724A (pt) | 2002-03-26 |
AU5540800A (en) | 2001-01-09 |
NO20016089D0 (no) | 2001-12-13 |
NO20016089L (no) | 2002-02-15 |
HUP0204524A2 (hu) | 2003-04-28 |
CA2375771A1 (fr) | 2000-12-28 |
WO2000078970A1 (fr) | 2000-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1578954A4 (en) | 5'-CPG NUCLEIC ACIDS AND USE METHOD | |
AU7680300A (en) | Human dna sequences | |
AU6069300A (en) | Novel human genes and gene expression products | |
IL148843A0 (en) | Immunostimulatory nucleic acids | |
IL147145A0 (en) | ANTI-αvβ3 RECOMBINANT HUMAN ANTIBODIES AND NUCLEIC ACIDS ENCODING THE SAME | |
EP1203008A4 (en) | NUCLEIC ACID LIGANDS AFFECTING THE CD40 LIGANDS | |
ZA987257B (en) | Amplification of nucleic acids | |
EP1125945A4 (en) | REVERSIBLE PHOTOCOUPLING NUCLEIC ACID AND PHOSPHORAMIDITE | |
EP0927270A4 (en) | PRESERVATION OF DNA AND RNA BY LYOPHILIZATION OF CULTIVATED HUMAN CELLS | |
GB9603069D0 (en) | Improvements in or relating to gene expression | |
EP1323735A4 (en) | GENE RELATING TO DRUG TOLERANCE AND USE THEREOF | |
EP1186615A4 (en) | PROTEIN AND DNA OF THIS PROTEIN | |
HUP0400492A3 (en) | Nucleic acids of the human abc1 gene and applications thereof | |
IL147071A0 (en) | Nucleic and proteinic acids corresponding to human gene abc1 | |
GB9515356D0 (en) | Improvements in or relating to delivery of nucleic acid | |
PL362867A1 (en) | Human heparanase-related polypeptide and nucleic acid | |
HUP0203848A3 (en) | Nucleic acid vaccination | |
HUP0201660A2 (en) | Novel polypeptide and dna thereof | |
GB0006408D0 (en) | Expression of DNA or proteins in C. Elegans | |
IL144849A0 (en) | Angiopoietin-related protein and nucleic acids | |
GB9917469D0 (en) | Extraction of nucleic acids | |
IL149185A0 (en) | Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application | |
AU1517500A (en) | Nucleic acids and proteins of the human span-x gene and uses thereof | |
AU3165500A (en) | Human nucleic acid and protein sequences obtained from endothelial cells | |
GB0015624D0 (en) | Materials and methods relating to improved gene delivery |